2020
DOI: 10.1016/j.jtumed.2020.04.004
|View full text |Cite
|
Sign up to set email alerts
|

Antimicrobial activity of cephalosporin–beta-lactamase inhibitor combinations against drug-susceptible and drug-resistant Pseudomonas aeruginosa strains

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 40 publications
0
3
0
Order By: Relevance
“…The most commonly encountered organisms were Escherichia coli , Klebsiella species, and Staphylococcus aureus . Though various studies have previously described susceptibility rates in several infectious isolates, Saudi data are limited either to single-center studies [ 7 , 12 20 ] or to research concentrating on the susceptibility to single or double antimicrobial classes [ 21 – 26 ].…”
Section: Discussionmentioning
confidence: 99%
“…The most commonly encountered organisms were Escherichia coli , Klebsiella species, and Staphylococcus aureus . Though various studies have previously described susceptibility rates in several infectious isolates, Saudi data are limited either to single-center studies [ 7 , 12 20 ] or to research concentrating on the susceptibility to single or double antimicrobial classes [ 21 – 26 ].…”
Section: Discussionmentioning
confidence: 99%
“…Biological activity produced by either compounds 11 or 12 against Escherichi coli and Staphylococcus aureus was evaluates using minimum inhibitory concentration (MIC). It is noteworthy that gentamicin (30S ribosomal subunit inhibitor), [41] ciprofloxacin (DNA gyrase inhibitor) [42] and cefotaxime (lactamase inhibitor) [43] were used as controls. The data found showed (figure 8) that growth bacterial of Staphylococcus aureus was inhibited by cefotaxime (MIC = 5.23×10 -4 mmol) and gentamicin (MIC = 2.68×10 -5 mmol).…”
Section: Evaluation Of Biological Activitymentioning
confidence: 99%
“… 7 Despite the growing evidence of successful treatment outcomes of MDR-PA using these two agents, we have previously shown that resistance to advanced cephalosporin-β-lactamase combinations was encountered among more than 65% of a MDR-PA cohort (n = 67) not previously exposed to the drug, of which >60% were found to have MIC > 256 µg/mL. 8 …”
Section: Introductionmentioning
confidence: 99%